Ny Sin completed his PhD in organic chemistry in 1996 at Syracuse University and a postdoctoral fellowship in the Department of Molecular, Cellular, and Developmental Biology at Yale in 1998. In the laboratory of Prof. Craig Crews, Dr. Sin successfully synthesized natural-product molecular probes and isolated their binding proteins. Following his fellowship at Yale, Dr. Sin worked for more than 17 years in research and development at Bristol-Myers Squibb, where he gained extensive experience solving complex problems in medicinal chemistry. Dr. Sin’s most recent research project at Bristol-Myers focused on the HIV maturation process, and he designed an HIV-1 maturation inhibitor, which is currently in clinical trial as a novel mechanism to treat HIV infection.

Dr. Sin has a variety of interests in synthetic organic and medicinal chemistry. In the IND, his work will focus on the synthesis of small molecules, with the aim of developing treatments for neurodegenerative diseases.